Dabigatran and thrombin modulate electrophysiological characteristics of pulmonary vein and left atrium

Circulation: Arrhythmia and Electrophysiology

Volumn 5, Issue 6, 2012, Pages 1176-1183

  Chang, Chien Jung ^a,c   Chen, Yao Chang ^d   Kao, Yu Hsun ^b   Lin, Yung Kuo ^a,b   Chen, Shih Ann ^e   Chen, Yi Jen ^a,b  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TUNGS' TAICHUNG METROHARBOR HOSPITAL   (Taiwan)

^d NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^e TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Atrial fibrillation; Direct thrombin inhibitor; Protease activated receptor; Pulmonary vein; Thrombin

Indexed keywords

DABIGATRAN; N(G) NITROARGININE METHYL ESTER; THROMBIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIASTOLE; HEART ATRIUM FIBRILLATION; HEART DEPOLARIZATION; HEART ELECTROPHYSIOLOGY; HEART LEFT ATRIUM; HEART MUSCLE FIBER MEMBRANE POTENTIAL; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PULMONARY VEIN; RABBIT; WESTERN BLOTTING;

ACTION POTENTIALS; ANIMALS; ANTITHROMBINS; ATRIAL FUNCTION; BENZIMIDAZOLES; BETA-ALANINE; COAGULANTS; ELECTROPHYSIOLOGICAL PHENOMENA; HEMOSTATICS; MALE; MODELS, ANIMAL; NITRIC OXIDE; PULMONARY VEINS; RABBITS; RECEPTOR, PAR-1; THROMBIN;

EID: 84873878421     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.112.971556     Document Type: Article

References (35)

1. Ren JF, Marchlinski FE, Callans DJ, Gerstenfeld EP, Dixit S, Lin D, Nayak HM, Hsia HH. Increased intensity of anticoagulation may reduce risk of thrombus during atrial fibrillation ablation procedures in patients with spontaneous echo contrast. J Cardiovasc Electrophysiol. 2005;16:474-477.
2. Zabalgoitia M, Halperin JL, Pearce LA, Blackshear JL, Asinger RW, Hart RG. Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke Prevention in Atrial Fibrillation III Investigators. J Am Coll Cardiol. 1998;31:1622-1626.
3. Choudhury A, Lip GY. Atrial fibrillation and the hypercoagulable state: from basic science to clinical practice. Pathophysiol Haemost Thromb. 2003;33:282-289.
4. Akar JG, Jeske W, Wilber DJ. Acute onset human atrial fibrillation is associated with local cardiac platelet activation and endothelial dysfunction. J Am Coll Cardiol. 2008;118:476-481.
5. Yan GX, Park TH, Corr PB. Activation of thrombin receptor increases intracellular Na+ during myocardial ischemia. Am J Physiol. 1995;268(4 pt 2):H1740-H1748.
6. Chien WW, Mohabir R, Clusin WT. Effect of thrombin on calcium homeostasis in chick embryonic heart cells. Receptor-operated calcium entry with inositol trisphosphate and a pertussis toxin-sensitive G protein as second messengers. J Clin Invest. 1990;85:1436-1443.
7. Albitz R, Droogmans G, Nilius B, Casteels R. Thrombin stimulates L-type calcium channels of guinea pig cardiomyocytes in cell-attached patches but not after intracellular dialysis. Cell Calcium. 1992;13:203-210.
8. Jiang T, Danilo P Jr, Steinberg SF. The thrombin receptor elevates intracellular calcium in adult rat ventricular myocytes. J Mol Cell Cardiol. 1998;30:2193-2199.
9. Pinet C, Le Grand B, John GW, Coulombe A. Thrombin facilitation of voltage-gated sodium channel activation in human cardiomyocytes: implications for ischemic sodium loading. Circulation. 2002;106:2098-2103.
10. Avkiran M, Haworth RS. Regulatory effects of G protein-coupled receptors on cardiac sarcolemmal Na+/H+ exchanger activity: signalling and significance. Cardiovasc Res. 2003;57:942-952.
11. Pinet C, Algalarrondo V, Sablayrolles S, Le Grand B, Pignier C, Cussac D, Perez M, Hatem SN, Coulombe A. Protease-activated receptor-1 mediates thrombin-induced persistent sodium current in human cardiomyocytes. Mol Pharmacol. 2008;73:1622-1631.
12. Steinberg SF, Robinson RB, Lieberman HB, Stern DM, Rosen MR. Thrombin modulates phosphoinositide metabolism, cytosolic calcium, and impulse initiation in the heart. Circ Res. 1991;68:1216-1229.
13. Jacobsen AN, Du XJ, Lambert KA, Dart AM, Woodcock EA. Arrhythmogenic action of thrombin during myocardial reperfusion via release of inositol 1,4,5-triphosphate. Circulation. 1996;93:23-26.
14. Woodcock EA, Matkovich SJ, Binah O. Ins(1,4,5)P3 and cardiac dysfunction. Cardiovasc Res. 1998;40:251-256.
15. Yang Z, Arnet U, Bauer E, von Segesser L, Siebenmann R, Turina M, Lüscher TF. Thrombin-induced endothelium-dependent inhibition and direct activation of platelet-vessel wall interaction. Role of prostacyclin, nitric oxide, and thromboxane A2. Circulation. 1994;89:2266-2272.
16. Kang KW, Choi SY, Cho MK, Lee CH, Kim SG. Thrombin induces nitric-oxide synthase via Galpha12/13-coupled protein kinase C-dependent I-kappaBalpha phosphorylation and JNK-mediated I-kappaBalpha degradation. J Biol Chem. 2003;278:17368-17378.
17. Chang SL, Chen YC, Chen YJ, Wangcharoen W, Lee SH, Lin CI, Chen SA. Mechanoelectrical feedback regulates the arrhythmogenic activity of pulmonary veins. Heart. 2007;93:82-88.
18. Haïssaguerre M, Jaïs P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Métayer P, Clémenty J. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998;339:659-666.
19. Chen SA, Hsieh MH, Tai CT, Tsai CF, Prakash VS, Yu WC, Hsu TL, Ding YA, Chang MS. Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation. Circulation. 1999;100:1879-1886.
20. Chen YJ, Chen SA. Electrophysiology of pulmonary veins. J Cardiovasc Electrophysiol. 2006;17:220-224.
21. Chen YJ, Chen SA, Chang MS, Lin CI. Arrhythmogenic activity of cardiac muscle in pulmonary veins of the dog: implication for the genesis of atrial fibrillation. Cardiovasc Res. 2000;48:265-273.
22. Lin YK, Lu YY, Chen YC, Chen YJ, Chen SA. Nitroprusside modulates pulmonary vein arrhythmogenic activity. J Biomed Sci. 2010;17:20.
23. Tsai WC, Chen YC, Lin YK, Chen SA, Chen YJ. Sex differences in the electrophysiological characteristics of pulmonary veins and left atrium and their clinical implication in atrial fibrillation. Circ Arrhythm Electrophysiol. 2011;4:550-559.
24. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L; RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361:1139-1151.
25. Lo LW, Chen YC, Chen YJ, Wongcharoen W, Lin CI, Chen SA. Calmodulin kinase II inhibition prevents arrhythmic activity induced by alpha and beta adrenergic agonists in rabbit pulmonary veins. Eur J Pharmacol. 2007;571:197-208.
26. Patterson E, Jackman WM, Beckman KJ, Lazzara R, Lockwood D, Scherlag BJ, Wu R, Po S. Spontaneous pulmonary vein firing in man: relationship to tachycardia-pause early afterdepolarizations and triggered arrhythmia in canine pulmonary veins in vitro. J Cardiovasc Electrophysiol. 2007;18:1067-1075.
27. Park TH, McHowat J, Wolf RA, Corr PB. Increased lysophosphatidylcholine content induced by thrombin receptor stimulation in adult rabbit cardiac ventricular myocytes. Cardiovasc Res. 1994;28:1263-1268.
28. Kalifa J, Jalife J, Zaitsev AV, Bagwe S, Warren M, Moreno J, Berenfeld O, Nattel S. Intra-atrial pressure increases rate and organization of waves emanating from the superior pulmonary veins during atrial fibrillation. Circulation. 2003;108:668-671.
29. Kwong K, Nassenstein C, de Garavilla L, Meeker S, Undem BJ. Thrombin and trypsin directly activate vagal C-fibres in mouse lung via protease-activated receptor-1. J Physiol (Lond). 2010;588(pt 7):1171-1177.
30. Gudmundsdóttir IJ, Megson IL, Kell JS, Ludlam CA, Fox KA, Webb DJ, Newby DE. Direct vascular effects of protease-activated receptor type 1 agonism in vivo in humans. Circulation. 2006;114:1625-1632.
31. Ziolo MT, Kohr MJ, Wang H. Nitric oxide signaling and the regulation of myocardial function. J Mol Cell Cardiol. 2008;45:625-632.
32. Ring A, Clemens A, Rathgen K, Stangier J, Feifel U, Reilly P, Friedman J. Dabigatran does not prolong the QTC interval with supratherapeutic exposure: a thorough QTC study. J Am Coll Cardiol. 2011;57:E56.
33. Wang Z, Ginnan R, Abdullaev IF, Trebak M, Vincent PA, Singer HA. Calcium/Calmodulin-dependent protein kinase II delta 6 (CaMKIIdelta6) and RhoA involvement in thrombin-induced endothelial barrier dysfunction. J Biol Chem. 2010;285:21303-21312.
34. Roberts DE, Matsuda T, Bose R. Molecular and functional characterization of the human platelet Na(+) /Ca(2+) exchangers. Br J Pharmacol. 2012;165:922-936.
35. Wongcharoen W, Chen YC, Chen YJ, Chang CM, Yeh HI, Lin CI, Chen SA. Effects of a Na+/Ca2+ exchanger inhibitor on pulmonary vein electrical activity and ouabain-induced arrhythmogenicity. Cardiovasc Res. 2006;70:497-508.